000			02291 a2200601 4500
005			20250515041613.0
264		0	_c20070123
008			200701s 0 0 eng d
022			_a0969-9961
024	7		_a10.1016/j.nbd.2006.07.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aFernandez-Gomez, F J
245	0	0	_aPyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression. _h[electronic resource]
260			_bNeurobiology of disease _cNov 2006
300			_a296-307 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aAntioxidants _xmetabolism
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCerebellar Cortex _xdrug effects
650	0	4	_aCytoprotection _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xdrug effects
650	0	4	_aGlutathione Peroxidase _xdrug effects
650	0	4	_aLipid Peroxidation _xdrug effects
650	0	4	_aNerve Degeneration _xdrug therapy
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xmetabolism
650	0	4	_aNeurotoxins _xantagonists & inhibitors
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aOxidopamine _xantagonists & inhibitors
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aProto-Oncogene Proteins c-akt _xdrug effects
650	0	4	_aPyruvic Acid _xmetabolism
650	0	4	_aRNA, Messenger _xdrug effects
650	0	4	_aRats
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aUp-Regulation _xdrug effects
700	1		_aPastor, M D
700	1		_aGarcia-Martinez, E M
700	1		_aMelero-Fernandez de Mera, R
700	1		_aGou-Fabregas, M
700	1		_aGomez-Lazaro, M
700	1		_aCalvo, S
700	1		_aSoler, R M
700	1		_aGalindo, M F
700	1		_aJordán, J
773	0		_tNeurobiology of disease _gvol. 24 _gno. 2 _gp. 296-307
856	4	0	_uhttps://doi.org/10.1016/j.nbd.2006.07.005 _zAvailable from publisher's website
999			_c16558006 _d16558006